You are here

UCB

J&J unwraps pivotal data on $6.5B autoimmune asset as it prepares to crash argenx and UCB's party

Fierce Biotech

Mon, 07/1/24 - 11:23 am

myasthenia gravis

clinical trials

UCB Wins FDA Approval for Plaque Psoriasis Therapy After Regulatory Setbacks

BioSpace

Thu, 10/19/23 - 10:15 am

Finding the big spenders beyond big pharma

EP Vantage

Mon, 04/24/23 - 10:15 am

Gilead Sciences

Moderna Therapeutics

Regeneron Pharmaceuticals

Vertex Pharmaceuticals

Big pharma holds steady on research spending

EP Vantage

Fri, 04/21/23 - 10:03 am

Takeover-driven resurgence fails to materialize for biotech

EP Vantage

Thu, 04/14/22 - 10:41 am

Halozyme Therapeutics

Samsung Bioepis

Amgen, Takeda, UCB enroll first patient in Covid-19 global platform study

Pharmaceutical Business Review

Wed, 12/2/20 - 10:24 am

clinical trials

COVID R&D Alliance

Amgen, UCB Drug Increases Bone Density in Phase 2 Trial

Drug Discovery and Development

Fri, 01/3/14 - 12:50 pm

Amgen announces data from romosozumab, Prolia studies

The Fly on the Wall

Fri, 10/4/13 - 11:17 am

bone mineral density

Top 10 rheumatoid arthritis drugs 2013

Fierce Pharma

Wed, 09/18/13 - 10:27 am

rheumatoid arthritis

Bristol-Myers Squibb

UCB - ConfometRx Collaborate

Yahoo/Zacks

Fri, 02/22/13 - 10:48 am

G protein coupled receptors

Lyrica matches UCB drug in Pfizer's latest epilepsy trial

Fierce Pharma

Thu, 02/21/13 - 12:34 pm